BioSpace News Archive

With the massive rise in the hospitals across the globe, pharmaceutical companies can expect a promising rise in growth opportunities in the hospital pharmaceutical sector, observes Transparency Market Research in a recent report.

According to a recent Transparency Market Research study, the global Advanced global advanced Visualization Systems market is set to see an impressive CAGR of 6.4% in the forecast period of 2016 to 2024.

An oxygen concentrator refers to a gadget that is tasked with the job of concentrating oxygen from a gas supply.

With substantial strides in medical technology alongside the deployment of the Internet of Things across the healthcare sector, the infrastructural growth of the developed and developing nations has paved the way for the expansion of the global market for automated compound storage and retrieval.

Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay for the detection of gluten, SENSISpec Ingezim Gluten R5, has been granted AOAC Research Institute Performance Tested MethodsSM status for use with gluten free bread, oat flour and stainless steel surfaces.

Aptitude’s Axess Network provides Excelera members with cutting-edge clinical and market insights in oncology and hematology as well as unparalleled access to disease-state experts and their clinical practices

Upjohn Inc., a wholly-owned subsidiary of Pfizer Inc., Upjohn Finance B.V., a wholly-owned subsidiary of Newco, Pfizer and Mylan N.V. announced the pricing of a private offering of $7.45 billion aggregate principal amount of Newco’s senior, U.S. dollar-denominated notes and a private offering of €3.60 billion aggregate principal amount of Finco’s senior, euro-denominated notes

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, today announced its financial results for the three months ended March 31, 2020

CareDx congratulates C-Path’s Transplant Therapeutics Consortium on utilizing iBox to streamline the development of novel transplant drugs

Aims to Inform use of Minimal Residual Disease (MRD) Monitoring in Clinical Trial Protocols and Future Therapy Optimization